about
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateRelevance of tumor-infiltrating lymphocytes in breast cancerStructural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapyAcute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesDevelopment of 1-N-(11)C-Methyl-L- and -D-Tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-Methyl-Tryptophan.MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.Gut microbiota modulation of chemotherapy efficacy and toxicity.Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.Programmed death-1 & its ligands: promising targets for cancer immunotherapy.Drug repurposing in oncology--patient and health systems opportunities.A perspective on the impact of radiation therapy on the immune rheostat.Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Identification of Small Novel Coding Sequences, a Proteogenomics Endeavor.Radiotherapy and immunotherapy: a beneficial liaison?Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases.Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neckIn-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide.Tumor Immunology, toward a Success Story?Limitation of tuning the antibody-antigen reaction by changing the value of pH and its consequence for hyperthermiaCancer vaccine strategies: translation from mice to human clinical trials.Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.
P2860
Q26765115-E10111D2-3D40-48D5-BC3F-06444DA2D064Q26777205-A9065BAA-3F63-4FCA-87F4-5E71DCB23BE7Q26795598-E8614A13-9714-4AF2-96D2-EA784F64291DQ28314934-0BAE5D03-4927-4FFA-AF88-D3AFFD818E6AQ30641952-DB9D3279-2366-45F0-B05D-4FAF32C60568Q35785160-D590BB1D-2C23-4CAA-A406-B4E975CF3B99Q36265787-67EE26CF-D9C6-4521-A959-0C5D12C8176FQ36293500-80FAF387-FCA2-4109-8008-0C793CA49F11Q36300217-9D7DB907-1012-476C-8C74-95248B78B21EQ37100703-1816A19D-64DA-4883-BC33-A2193745113CQ38349665-74B554A3-6ABE-45C7-9156-382AF546B495Q38562062-CD3A0AE9-8774-4D6E-A92D-A472BAD28EF6Q38611707-B99626D9-C3C9-4A05-BF09-1FB6695726D5Q38679488-FB35F55D-1E7A-4B3C-8236-92DE6A1037ABQ38779887-B6244AA4-4D2B-4859-B6EE-7D65D529DB1EQ38848219-48B9B29A-36A0-4029-967F-24AF678106F3Q38968213-8C10A9F0-0C3F-4990-91D1-2107C73DCE81Q39017268-37A556BE-DD23-42CF-AC48-B9CE27511C6BQ39412983-EC3BC204-1DD5-4220-8D00-6D006B1EAF5FQ39999283-920B9185-2011-4BD6-94AD-69468B5ABC10Q40493152-5C574D71-009F-4377-B53A-802C0B7F1F94Q41836009-9CA5DCC5-9F59-4E47-B271-DD417343A10DQ41979866-F1CAF609-ACC9-4475-96DA-7EBFB1F4F598Q48295639-964B241E-DE56-45DE-BB01-F2DA0993334CQ53064214-0FDA11BA-9991-4FE9-824C-D08435C0F583
P2860
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в листопаді 2014
@uk
name
Antitumour immunity gets a boost
@en
Antitumour immunity gets a boost
@nl
type
label
Antitumour immunity gets a boost
@en
Antitumour immunity gets a boost
@nl
prefLabel
Antitumour immunity gets a boost
@en
Antitumour immunity gets a boost
@nl
P2860
P356
P1433
P1476
Cancer: Antitumour immunity gets a boost
@en
P2093
Jedd D Wolchok
Timothy A Chan
P2860
P2888
P304
P356
10.1038/515496A
P407
P577
2014-11-01T00:00:00Z
P6179
1034403845